Development of novel ATMP through confirmatory pre-clinical testing to target both the underlying pathology driving cartilage degeneration and promote rapid tissue regeneration.
RCSI
Development of novel ATMP through confirmatory pre-clinical testing to target both the underlying pathology driving cartilage degeneration and promote rapid tissue regeneration.
Last Updated:
Last Updated:

To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...

On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...